REBER GENETICS CO LTD has a total of 22 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States, Republic of Korea and Taiwan. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are VLP THERAPEUTICS LLC, MOLMED SPA and AERAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Republic of Korea | 3 | |
#3 | Taiwan | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Chang Hsiu-Kang | 14 |
#2 | Chou Wei-I | 13 |
#3 | Chang Chia-Jung | 10 |
#4 | Lai Pao-Yen | 7 |
#5 | Chien Yu-Hsin | 7 |
#6 | Tsai Meng-Ju | 7 |
#7 | Liao Yan-Chiou | 6 |
#8 | Chang Jen-Yu | 4 |
#9 | Yang Cheng-Xin | 4 |
#10 | Chang Hsiu Kang | 2 |
Publication | Filing date | Title |
---|---|---|
US2021100887A1 | Recombinant fusion protein and immunogenic composition | |
US2021060154A1 | Vaccine composition and method of preventing porcine epidemic diarrhea virus infection in swine | |
US2020306359A1 | Immunogenic composition and method of enhancing immune response in hosts | |
CN107847575A | For pig reproduction and breathing syndrome and the vaccine combination of porcine circovirus associated diseases | |
CA2985227A1 | Novel baculovirus vectors and methods of use |